neurodegenerative disease

In this blog, the Editor-in-Chief of Molecular Brain, Bong-Kiun Kaang, discusses his groups findings from their recently published Micro report in the… Read more »

A recent commentary published in Alzheimer's Research and Therapy highlights the benefits and flaws of the new FDA guidelines for Alzheimer's drug… Read more »